Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-22-000006

Chief Medical Officer sold 2,845 shares at $44.78 ($127,399)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Carole Chief Medical Officer 2022-01-05 Sale −2,845 $44.78 $127,399 163,285 I: show line 1 in the form
Open-market sales · 2,845 sh · avg $44.78 · $127,399
Loading xslF345X03/wf-form4_164159673634515.xml…